Developmental toxicity of dextromethorphan in zebrafish embryos/larvae

Journal of Applied Toxicology

Volumn 31, Issue 2, 2011, Pages 157-163

  Xu, Zheng ^a   Williams, Frederick E ^a   Liu, Ming Cheh ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Cytosolic sulfotransferase; Developmental toxicity; Dextromethorphan; SULT; Zebrafish

Indexed keywords

DEXTROMETHORPHAN;

ARTICLE; BEHAVIOR; BLADDER; BLOOD FLOW; BRADYCARDIA; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL TOXICITY; DOSE RESPONSE; DRUG EXPOSURE; DRUG METABOLISM; EMBRYO; FEEDING; FERTILIZATION; GILL; HATCHING; HEART EDEMA; LARVA; LARVAL DEVELOPMENT; LORDOSIS; MORTALITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY; YOLK SAC; ZEBRA FISH;

ANIMALS; ANTITUSSIVE AGENTS; BEHAVIOR, ANIMAL; BRADYCARDIA; CRANIOFACIAL ABNORMALITIES; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; EDEMA, CARDIAC; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LARVA; REGIONAL BLOOD FLOW; RNA, MESSENGER; SULFOTRANSFERASES; TERATOGENS; YOLK SAC; ZEBRAFISH; ZEBRAFISH PROTEINS;

DANIO RERIO;

EID: 79951978839     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1576     Document Type: Article

References (43)

1. Alestrom P, Holter JL, Nourizadeh-Lillabadi R. 2006. Zebrafish in functional genomics and aquatic biomedicine. Trends Biotechnol. 24: 15-21.
2. American Academy of Pediatrics. 1997. Use of codeine- and dextromethorphan-containing cough remedies in children. American Academy of Pediatrics. Committee on Drugs. Pediatrics 99: 918-920.
3. Barker EV, Hume R, Hallas A, Coughtrie WH. 1994. Dehydroepiandrosterone sulfotransferase in the developing human fetus: quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes. Endocrinology 134: 982-989.
4. Beis D, Stainier DY. 2006. In vivo cell biology: following the zebrafish trend. Trends Cell Biol. 16: 105-112.
5. Bem JL, Peck R. 1992. Dextromethorphan. An overview of safety issues. Drug Saf. 7: 190-199.
6. Boland DM, Rein J, Lew EO, Hearn WL. 2003. Fatal cold medication intoxication in an infant. J. Anal. Toxicol. 27: 523-526.
7. Brion F, Tyler CR, Palazzi X, Laillet B, Porcher JM, Garric J, Flammarion P. 2004. Impacts of 17beta-estradiol, including environmentally relevant concentrations, on reproduction after exposure during embryo-larval-, juvenile- and adult-life stages in zebrafish (Danio rerio). Aquat. Toxicol. 68: 193-217.
8. Busquet F, Nagel R, von Landenberg F, Mueller SO, Huebler N, Broschard TH. 2008. Development of a new screening assay to identify proteratogenic substances using zebrafish danio rerio embryo combined with an exogenous mammalian metabolic activation system (mDarT). Toxicol. Sci. 104: 177-188.
9. Center for Disease Control and Prevention, 2007. Infant deaths associated with cough and cold medications - two states. 2005. MMWR Morb. Mortal. Weekly Rep. 56: 1-4.
10. Chang CY, Sachs HC, Lee CE. 2009. Unexpected infant deaths associated with use of cough and cold medications. Pediatrics 123: e358-359.
11. Chyka PA, Erdman AR, Manoguerra AS, Christianson G, Booze LL, Nelson LS, Woolf AD, Cobaugh DJ, Caravati EM, Scharman EJ etal. 2007. Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin. Toxicol. (Phil.) 45: 662-677.
12. Darras VM, Hume R, Visser TJ. 1999. Regulation of thyroid hormone metabolism during fetal development. Mol. Cell. Endocrinol. 151: 37-47.
13. Dart RC, Paul IM, Bond GR, Winston DC, Manoguerra AS, Palmer RB, Kauffman RE, Banner W, Green JL, Rumack BH. 2009. Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications. Ann. Emerg. Med. 53: 411-417.
14. David A, Pancharatna K. 2009. Effects of acetaminophen (paracetamol) in the embryonic development of zebrafish, Danio rerio. J. Appl. Toxicol. 29: 597-602.
15. Dickerson DL, Schaepper MA, Peterson MD, Ashworth MD. (2008). Coricidin HBP abuse: patient characteristics and psychiatric manifestations as recorded in an inpatient psychiatric unit. J. Addict. Dis. 27: 25-32.
16. Duanmu Z, Weckle A, Koukouritaki SB, Hines RN, Falany JL, Falany CN, Kocarek TA, Runge-Morris M. 2006. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J. Pharmacol. Exp. Ther. 316: 1310-1317.
17. Gurvich N, Berman MG, Wittner BS, Gentleman RC, Klein PS, Green JB. 2005. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. FASEB J. 19: 1166-1168.
18. Hakkola J, Tanaka E, Pelkonen O. 1998. Developmental expression of cytochrome P450 enzymes in human liver. Pharmacol. Toxicol. 82: 209-217.
19. Hillegass JM, Villano CM, Cooper KR, White LA. 2008. Glucocorticoids alter craniofacial development and increase expression and activity of matrix metalloproteinases in developing zebrafish (Danio rerio). Toxicol. Sci. 102: 413-424.
20. Hines RN. 2007. Ontogeny of human hepatic cytochromes P450. J. Biochem. Mol. Toxicol. 21: 169-175.
21. Hines RN. 2008. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol. Ther. 118: 250-267.
22. Ingham PW. 2009. The power of the zebrafish for disease analysis. Hum. Mol. Genet. 18: R107-112.
23. Jacqz-Aigrain E, Funck-Brentano C, Cresteil T. 1993. CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans. Pharmacogenetics 3: 197-204.
24. Kerry NL, Somogyi AA, Bochner F, Mikus G. 1994. The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes. Br. J. Clin. Pharmacol. 38: 243-248.
25. Kupfer A, Schmid B, Pfaff, G. 1986. Pharmacogenetics of dextromethorphan O-demethylation in man. Xenobiotica 16: 421-433.
26. Levin ED, Chrysanthis E, Yacisin K, Linney E. 2003. Chlorpyrifos exposure of developing zebrafish: Effects on survival and long-term effects on response latency and spatial discrimination. Neurotoxicol Teratol. 25: 51-57.
27. Marinetti L, Lehman L, Casto B, Harshbarger K, Kubiczek P, Davis J. 2005. Over-the-counter cold medications-postmortem findings in infants and the relationship to cause of death. J. Anal. Toxicol. 29: 738-743.
28. McCarver DG, Hines RN. 2002. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J. Pharmacol. Exp. Ther. 300: 361-366.
29. Menegola E, Di Renzo F, Broccia ML, Giavini E. 2006. Inhibition of histone deacetylase as a new mechanism of teratogenesis. Birth Defects Res. C. Embryol. Today 78: 345-353.
30. Milan DJ, Peterson TA, Ruskin JN, Peterson RT, MacRae CA. 2003. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107: 1355-1358.
31. Murakami SL, Cunningham LL, Werner LA, Bauer E, Pujol R, Raible DW, Rubel EW. 2003. Developmental differences in susceptibility to neomycin-induced hair cell death in the lateral line neuromasts of zebrafish (Danio rerio). Hear Res. 186: 47-56.
32. Oesterheld JR. 1998. A review of developmental aspects of cytochrome P450. J. Child Adolesc. Psychopharmacol. 8: 161-174.
33. Parng C, Seng WL, Semino C, McGrath P. 2002. Zebrafish: A preclinical model for drug screening. Assay Drug Dev. Technol. 1: 41-48.
34. Richard K, Hume R, Kaptein E, Stanley EL, Visser TJ, Coughtrie MW. 2001. Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J. Clin. Endocrinol. Metab. 86: 2734-2742.
35. Rimsza ME, Newberry S. 2008. Unexpected infant deaths associated with use of cough and cold medications. Pediatrics 122: e318-322.
36. Spitsbergen JM, Tsai HW, Reddy A, Miller T, Arbogast D, Hendricks JD, Bailey GS. 2000. Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N'-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol. Pathol. 28: 716-725.
37. Teraoka H, Dong W, Ogawa S, Tsukiyama S, Okuhara Y, Niiyama M, Ueno N, Peterson RE, Hiraga T. 2002. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin toxicity in the zebrafish embryo: altered regional blood flow and impaired lower jaw development. Toxicol. Sci. 65: 192-199.
38. Van LM, Sarda S, Hargreaves JA, Rostami-Hodjegan A. 2009. Metabolism of dextrorphan by CYP2D6 in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism. J. Pharm. Sci. 98: 763-771.
39. Veldman MB, Lin S. 2008. Zebrafish as a developmental model organism for pediatric research. Pediatr. Res. 64: 470-476.
40. Wingert WE, Mundy LA, Collins GL, Chmara ES. (2007). Possible role of pseudoephedrine and other over-the-counter cold medications in the deaths of very young children. J. Forensic Sci. 52: 487-490.
41. Wixon J. 2000. Featured organism: Danio rerio, the zebrafish. Yeast 17: 225-231.
42. Woo T. 2008. Pharmacology of cough and cold medicines. J. Pediatr. Health Care 22: 73-79.
43. Zhang Z, Balmer JE, Lovlie A, Fromm SH, Blomhoff R. 1996. Specific teratogenic effects of different retinoic acid isomers and analogs in the developing anterior central nervous system of zebrafish. Dev. Dyn. 206: 73-86.